The focus of most emerging therapeutic strategies currently is on developing glycolysis and lactate inhibitors, with few interventions directly targeting Kla pathways, leaving significant room for exploration
Importantly, the receptor for GLP-1 (GLP-1R) is abundantly expressed by vagal afferents 12,26,27 and physiological studies indicate that peripheral nerves are, at least in part, necessary for both endogenous GLP-1 and administered GLP-1 receptor agonists satiating and incretin effects 12,28,29,30,31,32
Thus, the transition from "physiological" to "pathological" fibrosis is driven by impaired apoptosis of myofibroblasts, as well as excessive ECM deposition and accumulation, resembling a persistent wound-healing response
That's how confident I am of this course
MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels